Skip to main content
Life inside the Protection of Civilians sites in South Sudan

Between war and fragile health systems, tackling TB in Sudan and South Sudan

War in Gaza:: find out how we're responding
Learn more

Years of war and a fragile health system have left many people without access to treatment for chronic infectious diseases such as tuberculosis (TB) in South Sudan, where about 14,000 cases are reported every year, according to the World Health Organization (WHO).

In neighbouring Sudan, the number of detected cases is higher, 20,000, although the population is about four times bigger. If left untreated, TB severely weakens people and can be fatal; it is one of the top 10 causes of death worldwide.

Over recent years, Médecins Sans Frontières (MSF) has integrated the diagnosis and treatment of TB into some of our medical programmes in Sudan and South Sudan in order to help tackle this disease. Our teams treat refugees, internally displaced people and local communities. New and innovative tools, such as the point-of-care-ultrasound (Pocus) and rapid diagnostic machine GeneXpert, are making TB faster and easier to diagnose.


Tackling TB in Sudan

Musab Sahnon/MSF

Without a proper diagnosis, people with TB may be given the wrong treatment, with the result that they fail to recover from the disease. The volatile situation in South Sudan’s Upper Nile region and Sudan’s White Nile state, where conflict frequently results in people moving from one place to another, can also result in TB patients interrupting their treatment, raising the risk that they will develop resistance to anti-TB drugs.

MSF patients and medical staff in Sudan and South Sudan describe the challenges and successes of treating TB in this difficult context.

“Now I have recovered. I can walk easily and I am fit again”

John Jimis, 28, is from Malakal in South Sudan. He arrived in Sudan as a refugee in 2017, re-joining his family who had already fled the war in their country. According to UNHCR, there are about 250,000 South Sudanese refugees in White Nile state, in Sudan’s south, most of them living in camps like Al-Kahafa.

Tackling TB in Sudan
Portrait of MSF TB patient John Jimis, 28, from Malakal in South Sudan, now a refugee in Sudan. January 2020.
Igor G. Barbero / MSF/MSF

“I was coughing all the time and I wasn’t sleeping well. I kept going to the health centre in Jorey refugee camp. They gave me medication, but I wasn’t getting any better. I saw the doctor three times or more, but my weight kept dropping.

My relatives took me to MSF’s hospital in Al-Kashafa. When I arrived, I was very sick, and I couldn’t sleep at night. I was brought into the hospital unconscious, weighing just 45 kilograms. They took a sputum sample and confirmed I had TB.

Now I have recovered. After two months I went back to the hospital and they took my sputum again. When I went back, my weight was 54 kilograms and it continues to increase.

The doctor has changed my medication to start the next phase of treatment. I’m taking the medication now. I can walk easily, and I’m fit and healthy, thanks be to God. I am very happy as I didn’t expect such a quick recovery.”

“Due to the conflict, many TB patients had their treatment disrupted”

Yumo Arop is MSF’s TB and HIV supervisor in White Nile state, Sudan.

Al Kashafa Hospital
Yumo Arop, MSF HIV and tuberculosis supervisor, stands outside MSF’s hospital in Al-Kashafa refugee camp. White Nile state, Sudan, October 2019.
MSF/Igor Barbero

“In Sudan, there were cases of TB before the arrival of refugees from South Sudan, but the refugees’ basic and congested living conditions – the lack of clean water and the poor sanitation – create the perfect environment for some diseases to spread.

When a new crisis broke out in 2017 in northeast South Sudan, with violent fighting, thousands of people crossed to neighbouring White Nile state in Sudan. Most of the new arrivals settled in Khor Waral refugee camp.

We screened the health of the newcomers and confirmed that some had TB. Some had been receiving treatment already in South Sudan, but due to the conflict and their displacement, many had their treatment disrupted. Some people had gone six or eight months without being treated. Health promoters helped identify possible patients and referred them to our hospital in Al-Kashafa refugee camp.

It was important to restart their treatment to prevent the expansion of the disease, as an infected person sitting in an overcrowded place can spread the disease to others, sometimes to their whole family. Prophylaxis [preventive treatment] needs to be distributed to the relatives.

If not treated properly, TB can lead to many issues, such as not being able to walk, loss of appetite, cough, body weakness, fever and death. The misuse of antibiotics can also lead to patients developing resistance. Luckily we only detected one case of resistant TB in 2018.”

“We get patients who have been feeling sick and showing symptoms for a long time”

Simon Dau, 42, is MSF’s clinical officer for HIV and TB in his hometown of Malakal in South Sudan. At the United Nations Protection of Civilians site in Malakal, where there are some 29,000 internally displaced people, the incidence of tuberculosis is about three times higher than the national rate.

“TB is very prevalent in South Sudan and the number of cases has been increasing with the years. I remember an uncle of mine who had a fever and a cough a few years ago, in 2011. We gave him amoxicillin and paracetamol but his condition didn’t improve at all and finally he died.

When I later joined MSF and got to know more about the disease, I became convinced that he had been suffering from TB. A lack of adequate health facilities and knowledge about the disease are factors that lead to the deaths of many people. In parts of South Sudan there are still no TB programmes at all. 

Tackling TB in South Sudan
An MSF staff member checks a sputum sample in a laboratory to confirm if the patient has TB. Malakal, South Sudan.
Alex McBride/MSF

When a patient suspected of having TB comes to visit us, I ask a set of standard questions: ‘Do you have a fever? Do you have a cough? Are you losing weight? When did your sickness start? What contacts did you have? Have you been treated for TB before?’

After taking the full history, we put the patient in isolation if they are very sick and take a sample of sputum. If the sample is positive for TB, we start treatment. We get patients who have been sick and showing symptoms for a long time. They may have gone first to private facilities without the capacity to diagnose TB. Sometimes they arrive at a late stage, when they are about to collapse.

If we suspect TB, we use the point-of-care ultrasound, or Pocus, to try to find some basic signs of TB, like pericardial and pleural effusions or lymph nodes. Pocus can also be used for many other purposes, such as paediatrics and surgery, as it replaces radiography and is much more functional and easier to use. This is particularly useful in the remote contexts where MSF often works.

With a sample of fluids, mainly sputum, we confirm later with GeneXpert, an automatic machine that amplifies DNA. It can also detect if the form of TB is resistant. It gives results very quickly – in just two hours.

These machines are very useful. Before we would just use a microscope and we had to send samples for confirmation to the laboratory. This could take several days and was a more complicated process. Now everything is much quicker and more sensitive, or detects TB bacteria more easily.”

MSF started to treat TB in South Sudan in the mid-1990s. Initial programmes were run in Leer and Nasir in 1994 and later in Lankien in 2006. Between 2013 and 2019, MSF treated 10,139 patients for TB in South Sudan, an average of nearly 1,450 people per year. At present, we treat people in Agok, Malakal, Ulang, Bentiu and Lankien. Between 2017 and 2019, MSF has treated 919 TB patients in White Nile state, Sudan, an average of over 300 people per year.

Up Next
Project Update 3 February 2020